Navigation Links
JDRF Teams Up with Pfizer's Centers for Therapeutic Innovation to Support Novel Translational Research in Type 1 Diabetes
Date:11/4/2013

NEW YORK, Nov. 4, 2013 /PRNewswire-USNewswire/ -- JDRF, the leading global organization funding type 1 diabetes (T1D) research, announced today a partnership with Pfizer's Centers for Therapeutic Innovation (CTI) to support the development and translation of promising diabetes research. The collaboration, announced during the Partnering for Cures Conference in New York, will initially focus on co-funding projects in the fields of immune tolerance, diabetic nephropathy, and beta cell health. Capitalizing on JDRF's expertise in the field of T1D research and CTI's network of academic medical centers, the organizations will work together to identify and drive promising research projects.

"This is a very exciting partnership for JDRF with tremendous opportunities to work with Pfizer's Centers for Therapeutic Innovation to advance progress toward new treatments and therapies for people with type 1 diabetes," says Jeffrey Brewer, president and CEO of JDRF. "JDRF is dedicated to delivering tangible improvements in the treatment of type 1 diabetes that may improve outcomes for people with the disease until there is a cure and it no longer exists. By harnessing resources and expertise from both of our organizations, we can speed the development and delivery of better treatments that could improve millions of lives – a vision shared by JDRF and CTI."

CTI is a pioneering open-innovation partnering model designed by Pfizer, wherein Pfizer employees work side by side with leading scientific investigators and post-docs from academic medical centers to accelerate drug discovery and development. The partnership between JDRF and CTI exemplifies a results-driven model of collaboration that is enriching the landscape of research and development, where leading players from the non-profit world, industry, and academia work together to achieve tangible progress for patients. Under the terms of the collaboration, JDRF and Pfizer will co-fund up to four jointly-selected projects.

"CTI's business model is to build novel partnerships that combine our drug discovery expertise with external innovation, and we've found a great partner in JDRF," says Dr. Anthony J. Coyle, chief scientific offer at Pfizer's CTI. "Combining Pfizer's scientific resources with JDRF's deep knowledge of type 1 diabetes and excellent network of investigators, I believe we will be well-positioned to pursue better, more targeted medicines for diabetes patients."

About JDRF

JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF's goal is to progressively remove the impact of T1D from people's lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D.

As the largest charitable supporter of T1D research, JDRF is currently sponsoring $530 million in scientific research in 17 countries. In 2012 alone, JDRF provided more than $110 million to T1D research. More than 80 percent of JDRF's expenditures directly support research and research-related education. In 2012 Forbes magazine named JDRF one of its five All-Star charities, citing the organization's efficiency and effectiveness.

For more information, please visit jdrf.org.


'/>"/>
SOURCE JDRF
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
2. eCardio Teams Up with Heart Rhythm Society for Month-Long Campaign to Raise Awareness of Cardiac Arrhythmias
3. Upsher-Smith Teams Up With Epilepsy Foundation of Minnesota for 2012 Stroll for Epilepsy
4. Eaton Scientific Teams Up with Renowned Womens Sexual Health Expert Dr. Jennifer R. Berman, MD and Berman Sexual Health to Advance Tropine 3 Trials and Marketing
5. A Successful Launch of a New Oncology Product Requires Global Teams & Planning
6. Sony Medical Division Teams with Wills Eye Institute to Bring "Expert" Panel of Ophthalmologists to AAO 2012 Convention
7. Three-Time Gold Medalist Misty May-Treanor Teams Up with Abreva to Knock Out Cold Sores this Cold and Flu Season
8. As Cold and Flu Season Peaks, The American Association of Poison Control Centers Teams up with Scholastic to Educate 6th Graders about Over-the-Counter Medicine Safety
9. Blue Belt Technologies gibt Einstellung des kaufmännischen Führungsteams für die USA bekannt
10. Defeat Diabetes Foundation Teams with CoreMedica Laboratories to Provide Affordable and Reliable A1C Testing for Diabetics
11. Work around the Clock: How Global Virtual Teams Are Re-Defining the Productivity Paradigm for Leading Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
Breaking Medicine News(10 mins):